David E. Nix
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Pharmacology 54
- Antibiotics Pharmacokinetics and Efficacy 54
- Epidemiology 38
- Pneumonia and Respiratory Infections 14
- Fungal Infections and Studies 12
- Co-authors
- Jerome J. Schentag (28 shared papers)Alan Forrest (8 shared papers)Mary C. Birmingham (5 shared papers)Charles H. Ballow (3 shared papers)Charles A. Peloquin (13 shared papers)Thomas F. Goss (4 shared papers)Michael F. Wilson (1 shared paper)Paresh Dandona (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (24 papers)Annals of Pharmacotherapy (15 papers)Open Forum Infectious Diseases (10 papers)American Journal of Health-System Pharmacy (7 papers)Journal of Antimicrobial Chemotherapy (7 papers)
- Partner nations
- United StatesSaudi ArabiaUnited Kingdom
In The Last Decade
David E. Nix
139 papers receiving 5.8k citations
David E. Nix's Hit Papers
Peers
Comparison fields: 5 of 153
- Molecular Medicine 1.3k
- Applied Microbiology and Biotechnology 379
- Pharmacology 2.6k
- Epidemiology 2.4k
- Infectious Diseases 1.3k
Countries citing papers authored by David E. Nix
This map shows the geographic impact of David E. Nix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Nix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Nix more than expected).
Fields of papers citing papers by David E. Nix
This network shows the impact of papers produced by David E. Nix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Nix. The network helps show where David E. Nix may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Nix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients Hit paper breakdown → | 1993 | 972 |
| 2 | Procalcitonin increase after endotoxin injection in normal subjects. Hit paper breakdown → | 1994 | 770 |
| 3 | 2006 | 234 | |
| 4 | 2013 | 206 | |
| 5 | 1989 | 159 | |
| 6 | 1991 | 149 | |
| 7 | 1999 | 142 | |
| 8 | 1991 | 134 | |
| 9 | 1993 | 124 | |
| 10 | 1991 | 120 | |
| 11 | 1990 | 118 | |
| 12 | 2004 | 117 | |
| 13 | 1995 | 117 | |
| 14 | 1999 | 99 | |
| 15 | 2004 | 92 | |
| 16 | 1995 | 88 | |
| 17 | 1989 | 86 | |
| 18 | 2009 | 82 | |
| 19 | 1990 | 82 | |
| 20 | 2009 | 81 |
About David E. Nix
David E. Nix is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Molecular Medicine and Pediatrics, Perinatology and Child Health, having authored 144 papers that have together received 6.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (54 papers), Antibiotic Resistance in Bacteria (26 papers), Antibiotic Use and Resistance (14 papers), Pneumonia and Respiratory Infections (14 papers), Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (12 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). The work is most often cited by research in Molecular Medicine (1.3k citations), Applied Microbiology and Biotechnology (379 citations), Pharmacology (2.6k citations), Epidemiology (2.4k citations) and Infectious Diseases (1.3k citations). David E. Nix has collaborated with scholars based in United States, Saudi Arabia and United Kingdom. Frequent co-authors include Jerome J. Schentag, Alan Forrest, Mary C. Birmingham, Charles H. Ballow, Charles A. Peloquin, Thomas F. Goss, Michael F. Wilson, Paresh Dandona, M. Assicot and Ahmad Aljada. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Annals of Pharmacotherapy, Open Forum Infectious Diseases, American Journal of Health-System Pharmacy and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.